Stock Events

Stock Events

AVITA Medical 

A$3.02
59
+A$0.01+0.33% 05:25 Today

Statistics

Day High
3.03
Day Low
2.93
52W High
3.08
52W Low
1
Volume
421,579
Avg. Volume
535,236
Mkt Cap
231.01M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

5NovExpected
Q1 2025
Q2 2025
Q3 2025
Q4 2025
Q1 2026
Q2 2026
Next
-0.83
-0.66
-0.5
-0.33
Expected EPS
-0.3316575955239796
Actual EPS
N/A

Financials

-67.94%Profit Margin
Unprofitable
2020
2021
2022
2023
2024
2025
109.88MRevenue
-74.65MNet Income

Analyst Ratings

13.53Average Price Target
The highest estimate is 16.13.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy
100%
Hold
0%
Sell
0%

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Medtronic
MDT
Mkt Cap120.46B
Medtronic offers products in wound care and regenerative medicine, competing in the same space as AVITA's skin regeneration technology.
Johnson & Johnson
JNJ
Mkt Cap663.28B
Johnson & Johnson, through its subsidiary Ethicon, produces a range of wound closure products, directly competing with AVITA's regenerative medical solutions.
Stryker
SYK
Mkt Cap116.27B
Stryker Corporation provides medical devices and equipment that include products for wound management and surgical solutions, overlapping with AVITA's market.
Boston Scientific
BSX
Mkt Cap69.27B
Boston Scientific Corporation offers medical devices that are used in various surgical procedures, including those for wound care and tissue repair, competing with AVITA.
Zimmer Biomet
ZBH
Mkt Cap18.71B
Zimmer Biomet Holdings, Inc. focuses on musculoskeletal healthcare but has products in surgical wound management, indirectly competing with AVITA's offerings.
Intuitive Surgical
ISRG
Mkt Cap129.55B
Intuitive Surgical, Inc. specializes in robotic-assisted surgery, offering innovative solutions that could compete with traditional regenerative treatments offered by AVITA.
Abbvie
ABBV
Mkt Cap453.19B
AbbVie Inc. has a broad portfolio of medical products, including in dermatology and wound healing, which could compete with AVITA's skin regeneration products.
Pfizer
PFE
Mkt Cap162.16B
Pfizer Inc. has investments in regenerative medicine and tissue repair, areas that are directly competitive with AVITA Medical's core business.
Novartis
NVS
Mkt Cap304.1B
Novartis AG engages in the research, development, and marketing of healthcare products, including those in skin health and regeneration, competing with AVITA.
Baxter International
BAX
Mkt Cap13.35B
Baxter International Inc. provides a portfolio of hospital and surgical products, including advanced wound care, which competes with AVITA Medical's regenerative technology.

About

Avita is largely a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently used in most of the 140 US burn centers. Despite having product approval in Australia, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region, although international sales, particularly in Japan, are growing. Avita is domiciled, and has its primary listing, in the US.
Show more...
CEO
Cary G. Vance
Employees
226
Country
United States
ISIN
AU000000AVH4
WKN
000A2P8DT

Listings

MU
DE
51K.MU
MU
DE
GCR.MU
STU
DE
51KB.STU
MU
DE
51KB.MU

0 Comments

Share your thoughts

FAQ

What is AVITA Medical stock price today?▼
The current price of AVH.AU is A$3.02 AUD — it has increased by +0.33% in the past 24 hours. Watch AVITA Medical stock price performance more closely on the chart.
What is AVITA Medical stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Australia Exchange exchange AVITA Medical stocks are traded under the ticker AVH.AU.
Is AVITA Medical stock price growing?▼
AVH.AU stock has risen by +8.84% compared to the previous week, the month change is a +95.78% rise, over the last year AVITA Medical has showed a +125.84% increase.
What is AVITA Medical market cap?▼
Today AVITA Medical has the market capitalization of 231.01M
When is the next AVITA Medical earnings date?▼
AVITA Medical is going to release the next earnings report on November 05, 2026.
What were AVITA Medical earnings last quarter?▼
AVH.AU earnings for the last quarter are -0.36 AUD per share, whereas the estimation was -0.42 AUD resulting in a +14.62% surprise. The estimated earnings for the next quarter are N/A AUD per share.
What is AVITA Medical revenue for the last year?▼
AVITA Medical revenue for the last year amounts to 109.88M AUD.
What is AVITA Medical net income for the last year?▼
AVH.AU net income for the last year is -74.65M AUD.
How many employees does AVITA Medical have?▼
As of September 08, 2026, the company has 226 employees.
In which sector is AVITA Medical located?▼
AVITA Medical operates in the Health & Wellness sector.
When did AVITA Medical complete a stock split?▼
The last stock split for AVITA Medical was on June 10, 2008 with a ratio of 1:10.
Where is AVITA Medical headquartered?▼
AVITA Medical is headquartered in VALENCIA, United States.